[ad_1]
Citizen – follow up
Two new drugs, intended to prevent migraine attacks, will soon be introduced by the European Medicines Agency.
English and Scottish Health Authorities Investigate Marketed Drugs Erinumab and Imovig
Drug manufacturer Novartis has stated that patients may have access to the drug at their own cost starting in September, even though this drug does not have a drug. is not offered by the Health Services Authority
. Receptors in the brain called peptide receptors, which are thought to contribute to the attack of migraine, although scientists are not sure of the main cause of the most severe headaches.
The European Medicines Agency approved the drug for migraine patients at least 4 times a month. 19659007] Share on Facebook “/>
